ClinicalTrials.govpublic full text
A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus
cytomegalovirus disease, kidney transplant infection, cytomegalovirus, cmv, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 803855
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.